What do women think? study explores feel of vaginal products
NCT ID NCT01334827
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how 48 women felt about three different vaginal products: a low-volume gel, a high-volume gel, and a quick-dissolving film. The goal was to understand what women like and dislike about each product, which could help make future HIV prevention gels and films more acceptable. Participants used each product during sex and rated their sensory experiences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help design more acceptable vaginal microbicides, potentially improving HIV prevention options for women.
What could go wrong
This is a small, early-stage study focused on user perceptions, not on testing effectiveness against any disease. Results may not translate to real-world use or product success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROBICIDE DELIVERY SYSTEM ACCEPTABILITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Miriam Hospital
Providence, Rhode Island, 02906, United States